Exhibit 10.6

                                   Sales Plan

            Sales Plan, dated as of the date set forth on the signature page
(the "Sales Plan"), between Linda Stern ("Seller") and Goldman, Sachs & Co.
("Broker").

            WHEREAS, Seller desires to establish the Sales Plan to sell shares
of common stock, par value $0.10 per share (the "Stock"), of E-Z-EM, Inc. (the
"Issuer") in accordance with the requirements of Rule 10b5-1 under the
Securities Exchange Act of 1934, as amended (the "Exchange Act") as further set
forth herein;

            NOW, THEREFORE, Seller and Broker hereby agree as follows:

1. Broker shall effect one or more sales (each a "Sale") of shares of Stock (the
"Shares") as further set forth in the attached Annex A to this Sales Plan. All
orders will be deemed day market orders only and not held unless otherwise
specified in Annex A.

2. Seller is subject to certain limitations as set forth in a private letter
ruling from the IRS that provides that Sales of the Issuer's Stock should only
occur on the same date that Seller sells shares of AngioDynamics, Inc., and in
the same proportion to the outstanding shares of each of the Issuer and
AngioDynamics, Inc., respectively. It is the understanding of the parties to
this Sales Plan that Seller and Broker will also enter into a separate sales
plan relating to the sale by Seller of certain of its shares of common stock in
AngioDynamics, Inc. (the "ANGO Sales Plan") and that the commencement of Sales
under this Sales Plan is conditioned on the effectiveness of the ANGO Sales Plan
and the commencement of Sales thereunder. Annex A of this Sales Plan and Annex A
of the ANGO Sales Plan contemplate Sales of EZEM and ANGO, respectively, such
that Sales under each plan are to be made on the same Trading Day and in the
same proportion to the outstanding shares of each of the Issuer and
AngioDynamics, Inc., respectively.


3. This Sales Plan shall become effective as of the date hereof (the "Effective
Date") and Sales shall commence under Annex A on the date on which Sales
commence under the ANGO Sales Plan. This Sales Plan shall terminate on the
earliest of (a) December 29, 2006, (b) the date on which Broker has sold all
Shares specified in Annex A, (c) the date that this Sales Plan is terminated in
accordance with paragraph 12 below, (d) the date Broker receives notice of the
death or dissolution of Seller or (e) the date that the ANGO Sales Plan is
terminated in accordance with the provisions thereof (the period commencing on
the Effective Date and ending on the earliest to occur of (a), (b), (c), (d) or
(e) being referred to herein as the "Plan Sales Period").

4. Seller understands that Broker may effect Sales hereunder jointly with orders
for other sellers of Stock of the Issuer and that the average price for
executions resulting from bunched orders will be assigned to Seller's account.

5. Seller represents and warrants that, as of the date hereof, Seller is not
aware of material, nonpublic information with respect to the Issuer or any
securities of the Issuer (including the Stock) and is entering into this Sales
Plan in good faith and not as part of a plan or scheme to evade the prohibitions
of Rule 10b5-1.

<PAGE>

6. It is the intent of the parties that this Sales Plan comply with the
requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and this Sales
Plan shall be interpreted to comply with the requirements of Rule 10b5-1(c).
Seller has consulted with Seller's own advisors as to the legal and tax aspects
of Seller's adoption and implementation of this Sales Plan.

7. Seller represents that Seller may be deemed an "affiliate" of the Issuer as
that term is defined under Rule 144 of the Securities Act of 1933. Seller shall
not take, and shall not cause any person or entity with which he or she would be
required to aggregate sales of Stock pursuant to paragraph (a)(2) or (e) of Rule
144 to take, any action that would cause the Sales not to comply with Rule 144.
Seller has provided Broker with five (5) executed, partially completed Forms
144, which Broker will complete and file on behalf of the Seller. Seller
understands and agrees that unless otherwise agreed or instructed, Broker will
make one Form 144 filing as necessary at the beginning of each three-month
period commencing prior to the first Sale to be effected pursuant to this Plan,
and that such Form 144 shall specify that the Sales are being effected in
accordance with a Sales Plan intended to comply with Rule 10b5-1. Seller agrees
to provide Broker with such information as is reasonably necessary for Broker
accurately and timely to complete the Forms 144.

8. Seller represents and warrants that except for the requirements set forth
herein including any Rule 144 requirements, there are no contractual,
regulatory, or other restrictions applicable to the Sales contemplated under
this Sales Plan that would interfere with Broker's ability to execute Sales and
effect delivery and settlement of such Sales on behalf of Seller, other than
restrictions with respect to which the Seller has obtained all required
consents, approvals and waivers. Seller shall notify Broker immediately in the
event that any of the above statements become inaccurate prior to the
termination of this Sales Plan.

9. Seller will not directly or indirectly communicate any information relating
to Issuer or Issuer securities to any employee of Broker or its affiliates who
is directly or indirectly involved in executing this Sales Plan at any time
while this Sales Plan is in effect.

10. Seller shall make all filings, if any, required under Sections 13(d) and 16
of the Exchange Act. Seller and Broker have executed a "Broker's Authorization
to Confirm and Provide Reports of Transfers Directly to Issuer" in the form of
Annex B hereto, authorizing Broker to deliver notifications of Sales to the
Issuer.

11. Seller understands that Broker may not effect a Sale due to a market
disruption or a legal, regulatory or contractual restriction applicable to the
Broker or any other event or circumstance (a "Blackout"). Seller also
understands that even in the absence of a Blackout, Broker may be unable to
effect Sales consistent with ordinary principles of best execution due to
insufficient volume of trading, failure of the Stock to reach and sustain a
limit order price, or other market factors in effect on the date of a Sale set
forth in Annex A ("Unfilled Sales").

12. Broker agrees that if Issuer enters into a transaction that imposes trading
restrictions on the Seller, such as a stock offering requiring an affiliate
lock-up (an "Issuer Restriction"), and if Issuer and Seller shall provide Broker
at least three (3) days'

                                       2
<PAGE>

prior notice of such trading restrictions, then Broker will cease effecting
Sales under this Sales Plan until notified by Issuer and Seller that such
restrictions have terminated. In addition to the foregoing, to the extent that
an issuer restriction is imposed pursuant to the ANGO Sales Plan (an "ANGO
Issuer Restriction"), and Broker shall have received notice of such issuer
restriction in accordance with the provision of that plan, then Broker, in
addition any cessation of sales required under the ANGO Sales Plan, shall also
cease effecting Sales under this Sales Plan until notified in accordance with
the provisions of the ANGO Sales Plan that such restrictions have terminated.
All required notifications to Broker under this paragraph 12 shall be made in
writing (signed by Seller and Issuer) and confirmed by telephone as follows:
(Attn: Structured Equity Solutions, c/o Control Room; Fax No. (212) 902-0943;
Tel: (212) 902-1511). Broker shall resume effecting Sales in accordance with
this Sales Plan as soon as practicable after the cessation or termination of a
Blackout, Issuer Restriction or ANGO Issuer Restriction. Any Unfilled Sales, and
any Sales that would have been executed in accordance with the terms of Annex A
but are not executed due to the existence of a Blackout, Issuer Restriction or
ANGO Issuer Restriction, shall be deemed to be cancelled, and shall not be
effected pursuant to this Sales Plan.

13. This Sales Plan and its enforcement, and each transaction entered into
hereunder and all matters arising in connection with this Sales Plan and
transactions hereunder shall be governed by, and construed in accordance with,
the laws of the State of New York, without reference to its choice of law
doctrine. The Sales Plan may be modified, terminated or amended only by a
writing signed by the parties hereto (including the acknowledgement of the
Issuer) and provided that any such modification, or amendment shall only be
permitted at a time when the Seller is not aware of material nonpublic
information concerning the Issuer or AngioDynamics, Inc. or their securities. In
the event of a modification or amendment to this Sales Plan, or in the event
Seller establishes a new plan after termination of the Sales Plan, no sales
shall be effected during the thirty days immediately following such
modification, amendment or termination (other than Sales already provided for in
the Sales Plan prior to modification, amendment or termination).The parties
agree that any termination of the Sales Plan shall result in the simultaneous
termination of the ANGO Sales Plan.

14. Seller agrees that Broker and its affiliates and their directors, officers,
employees, and agents (collectively, "Broker Persons") shall not have any
liability whatsoever to Seller for any action taken or omitted to be taken in
connection with the Sales Plan, the making of any Sale, or any amendment,
modification or termination of the Sales Plan, unless such liability is
determined in a non-appealable order of a court of competent jurisdiction to
have resulted solely from the negligence, willful misconduct or bad faith of the
Broker Person. Seller further agrees to hold each Broker Person free and
harmless from any and all losses, damages, liabilities or expenses (including
reasonable attorneys' fees and costs) incurred or sustained by such Broker
Person in connection with or arising out of any suit, action or proceeding
relating to this Sales Plan, any Sale, or any amendment, modification or
termination of the Sales Plan (each an "Action") and to reimburse each Broker
Person for its expenses, as they are incurred, in connection with any Action,
unless such loss, damage, liability or expense is determined in a non-appealable
order of a court of competent jurisdiction to be solely the result of such
Broker Person's negligence, willful misconduct or bad faith. This paragraph 14
shall survive termination of this Sales Plan.


                                       3
<PAGE>

            IN WITNESS WHEREOF, the undersigned have signed this Sales Plan as
of the date below.

__________________________                 Goldman, Sachs & Co.
Linda Stern                                By: __________________
                                           Name: Michael Dweck
Date: _____________________                Title: Managing Director

Acknowledged:
E-Z-EM, INC.

By: _________________________
Name:
Title:


                                       4